In addition, people with coronary heart disease, atherosclerosis, hyperuricemia, liver and kidney diseases, hypertension, and medication were eliminated to exclude the influence of diseases on the plasma concentration of fibulin-1 in our study. This evidence concerns the gene FBLN1 and hypertensive disorder.